James River Group Holdings, Ltd. ("James River" or the "Company")
(NASDAQ: JRVR) today reported the following results for the third
quarter 2024 as compared to the same period in 20231:
|
Three Months EndedSeptember
30, |
|
Three Months EndedSeptember
30, |
($ in thousands,
except for share data) |
|
2024 |
|
|
per diluted share |
|
|
2023 |
|
|
per diluted share |
Net (loss) income from continuing operations available to common
shareholders |
$ |
(40,702 |
) |
|
$ |
(1.07 |
) |
|
$ |
21,097 |
|
|
$ |
0.55 |
|
Net loss from discontinued
operations |
|
(1,304 |
) |
|
$ |
(0.03 |
) |
|
|
(4,171 |
) |
|
$ |
(0.10 |
) |
Net (loss) income available to
common shareholders |
|
(42,006 |
) |
|
$ |
(1.10 |
) |
|
|
16,926 |
|
|
$ |
0.45 |
|
Adjusted net operating (loss)
income2 |
|
(28,196 |
) |
|
$ |
(0.74 |
) |
|
|
18,859 |
|
|
$ |
0.49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss from continuing operations available to common
shareholders was $40.7 million ($1.07 per diluted share). Adjusted
net operating loss2 of $28.2 million ($0.74 per diluted share) for
the third quarter of 2024 was largely attributable to the
previously announced $52.2 million of excess consideration paid
over reserves ceded in connection with the Excess and Surplus Lines
("E&S") combined loss portfolio transfer adverse development
reinsurance contract ("E&S ADC") that closed on July 2, 2024,
as well as $19.2 million of additional adverse development ceded to
the E&S ADC and recorded as a deferred reinsurance gain on the
Company's balance sheet, and $4.8 million of adverse development
retained by the Company. These were partially offset by strong
investment income and underwriting profit from our Specialty
Admitted segment.
Unless specified otherwise, all underwriting
performance ratios presented herein are for our continuing
operations and business not subject to retroactive reinsurance
accounting for loss portfolio transfers ("LPTs").
Third Quarter 2024 Highlights:
- E&S segment gross written
premium growth was 6% and positive renewal rate change of 8.6%.
While the segment reported a 136.1% combined ratio, the current
accident year combined ratio for the segment was 92.6%.
- Specialty
Admitted Insurance segment combined ratio of 91.3%, with fronting
and program gross written premium growth of 8.7% excluding the
non-renewed workers' compensation programs.
- Net investment
income increased 8.1% compared to the prior year quarter, with all
asset classes reporting higher income.
- Shareholders'
equity per share of $14.02 decreased 2.1% sequentially from June
30, 2024, due to the net loss from continuing operations, while
tangible common equity per share3 increased 1.9% sequentially.
Strategic Actions:
- The Company is
commencing a multi-pronged strategic partnership with Enstar Group
Limited ("Enstar"), a leader in P&C industry risk and liability
management, under which:
- Cavello Bay
Reinsurance Limited (“Cavello Bay”), a wholly owned subsidiary of
Enstar, has agreed to purchase $12.5 million of newly issued common
shares at a per share price of $6.40 (subject to certain closing
conditions), in addition to 637,640 common shares it already owns
through purchases in the open market; and
- Subsidiaries of
the Company have entered into an adverse development reinsurance
agreement with Cavello Bay, directly above the existing E&S
ADC, with a limit of $75 million and no co-participation4; and
- Enstar will also
have an informal consulting relationship and best practices
dialogue with the Company’s claims leadership.
- The Company
amended the convertible preferred shares held by Gallatin Point
Capital LLC ("Gallatin Point") to convert $37.5 million liquidation
preference of the outstanding preferred shares to common shares at
a per share price of $6.40. The quarterly preferred dividend of the
remaining $112.5 million liquidation preference will remain at 7%
for five years subsequent to September 30, 2024 and will be capped
at 8% thereafter. In addition, the voluntary and mandatory
conversion prices of the remaining $112.5 million of outstanding
preferred shares were amended to increase the conversion premiums
to 130% and 200% of the new conversion price of $6.40 per share,
respectively.
- Through these
actions, alongside the reduction to the Company's quarterly common
dividend, the Company will meaningfully reduce its fixed charges
given the opportunity it has to put capital to work at attractive
returns, in its E&S segment especially.
- The Company
intends to pursue a plan to redomicile to the United States during
2025 and expects to reduce its effective tax rate closer to the US
statutory rate thereafter.
- See the 2024 Strategic Actions Frequently Asked Questions
slides being made available on the Investor Relations page of our
website simultaneously with this press release for further
information on these Strategic Actions. With these announcements,
the Board of Directors have concluded the strategic review process
announced in November of 2023. While the strategic review process
has been completed, in the ordinary course of business the Company
expects to consider beneficial opportunities.
_______________1 The Company closed the sale of
JRG Reinsurance Company Ltd. on April 16, 2024. The full financials
for our former Casualty Reinsurance segment have been classified to
discontinued operations for all periods.2 Adjusted net operating
(loss) income, tangible common equity per share and adjusted net
operating return on tangible common equity are non-GAAP financial
measures. See “Non-GAAP Financial Measures” and “Reconciliation of
Non-GAAP Financial Measures” at the end of this press release.3
Percent change before $0.05 common dividends paid per share during
the third quarter of 2024. 4 The Enstar transactions are subject to
closing conditions, including receipt by Cavello Bay of regulatory
approval of the adverse development cover.
Frank D'Orazio, the Company’s Chief Executive
Officer, commented on the third quarter, “With the strategic
actions we are announcing - notably the addition of Enstar as both
a significant shareholder and strategic partner and the continued
commitment of Gallatin Point - our highly regarded E&S
franchise is significantly de-risked and well positioned to take
advantage of strong market support amid a robust E&S
environment. Momentum in our Core E&S franchise has continued
to build each quarter during 2024 as we continue to balance
attractive market conditions with underwriting discipline.”
David Ni, Chief Strategy Officer of Enstar Group, commented, “In
conjunction with these transactions, Enstar has had the opportunity
to become well-versed with the Company’s business and we are
pleased to make a $12.5 million common equity investment,
underscoring our support of James River and its E&S
franchise.”
Matthew Botein, Co-Founder and Managing Partner of Gallatin
Point Capital, commented, “I have seen the team at James River make
deep and meaningful improvements to the Company over the last
several years. These transactions are the culmination of those
efforts and Gallatin Point is very supportive of James River as it
enters a new phase, where it is poised to capitalize on the market
opportunity for its flagship E&S operation.”
Third Quarter 2024 Operating
Results
- Gross written premium of $330.4 million, consisting of the
following:
|
Three Months EndedSeptember
30, |
|
($ in thousands) |
|
2024 |
|
|
|
2023 |
|
|
% Change |
Excess and Surplus Lines |
$ |
230,215 |
|
|
$ |
217,151 |
|
|
|
6 |
% |
Specialty Admitted Insurance |
|
100,208 |
|
|
|
125,700 |
|
|
|
(20 |
)% |
|
$ |
330,423 |
|
|
$ |
342,851 |
|
|
|
(4 |
|
|
|
|
|
|
|
|
|
|
|
- Net written premium of $147.3 million, consisting of the
following:
|
Three Months EndedSeptember
30, |
|
($ in thousands) |
|
2024 |
|
|
|
2023 |
|
|
% Change |
Excess and Surplus Lines |
$ |
129,735 |
|
|
$ |
123,046 |
|
|
|
5 |
% |
Specialty Admitted Insurance |
|
17,603 |
|
|
|
22,936 |
|
|
|
(23 |
)% |
|
$ |
147,338 |
|
|
$ |
145,982 |
|
|
|
1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
- Net earned premium of $159.7 million, consisting of the
following:
|
Three Months EndedSeptember
30, |
|
($ in thousands) |
|
2024 |
|
|
|
2023 |
|
|
|
% Change |
|
Excess and Surplus Lines |
$ |
138,892 |
|
|
$ |
157,600 |
|
|
|
(12 |
)% |
Specialty Admitted Insurance |
|
20,834 |
|
|
|
26,073 |
|
|
|
(20 |
)% |
|
$ |
159,726 |
|
|
$ |
183,673 |
|
|
|
(13 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
- E&S Segment
Highlights:
- For the third
quarter of 2024, the segment grew 6%, and its casualty underwriting
divisions grew 6.7% as compared to the prior year quarter.
- Renewal rate
increases across the segment were 8.6% during the quarter.
- The segment
experienced its strongest submission growth in over four years,
with double digit growth in both new and renewal submissions.
- Specialty
Admitted Insurance Segment Highlights:
- Gross written premium for fronting and program business
increased 8.7% compared to the prior year quarter, excluding the
impact of our large workers’ compensation program and Individual
Risk Workers’ Compensation book.
- Gross written premium for the
Specialty Admitted Insurance segment declined 20.3% compared to the
third quarter of 2023, with the reduction due to the impact of the
non-renewed workers' compensation program during the second quarter
of 2023 and the sale of the renewal rights of the individual risk
workers’ compensation business during the third quarter of
2023.
-
Pre-tax favorable (unfavorable) reserve development by segment on
business not subject to retroactive reinsurance accounting for loss
portfolio transfers was as follows:
|
Three Months EndedSeptember
30, |
($ in thousands) |
|
2024 |
|
|
|
2023 |
|
Excess and Surplus Lines |
$ |
(57,041 |
) |
|
$ |
(7,809 |
) |
Specialty Admitted Insurance |
|
165 |
|
|
|
— |
|
|
$ |
(56,876 |
) |
|
$ |
(7,809 |
) |
|
|
|
|
|
|
|
|
-
The third quarter of 2024 reflected $57.0 million of net
unfavorable reserve development in the E&S segment and $0.2
million of favorable reserve development in the Specialty Admitted
Insurance segment. The Company ceded $71.4 million of year-to-date
unfavorable reserve development on business subject to the E&S
ADC. This consists of a $52.2 million reserve charge upon execution
of the E&S ADC equal to the excess consideration paid over
reserves ceded and additional adverse development of $19.2 million
that was ceded to the E&S ADC. The deferred retroactive
reinsurance gain on the balance sheet associated with the E&S
ADC is $19.2 million as of September 30, 2024. Additionally, the
Company recognized unfavorable gross reserve development of $0.9
million ($0.0 net) on the reserves subject to the Commercial Auto
LPT, which provides unlimited coverage.
-
Retroactive benefits of $2.2 million were recorded in loss and loss
adjustment expenses during the third quarter and the total deferred
retroactive reinsurance gain on the Balance Sheet is $31.0 million
as of September 30, 2024.
-
Gross fee income was as follows:
|
Three Months EndedSeptember
30, |
|
($ in thousands) |
|
2024 |
|
|
|
2023 |
|
|
|
% Change |
|
Specialty Admitted Insurance |
$ |
5,239 |
|
|
$ |
6,833 |
|
|
|
(23 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
-
The consolidated expense ratio was 31.4% for the third quarter of
2024, which was an increase from 26.4% in the prior year quarter.
The expense ratio increase was primarily driven by higher
compensation and bad debt expense, and lower net earned premium in
the E&S segment.
Investment Results
Net investment income for the third quarter of
2024 was $23.6 million, an increase of 8.1% compared to $21.8
million in the prior year quarter. Growth in income was broad-based
across the portfolio, as cash flow was deployed at higher
yields.
The Company’s net investment income consisted of
the following:
|
Three Months EndedSeptember
30, |
|
($ in
thousands) |
|
2024 |
|
|
|
2023 |
|
|
% Change |
Private Investments |
|
1,757 |
|
|
|
27 |
|
|
|
NM |
|
All Other Investments |
|
21,807 |
|
|
|
21,772 |
|
|
|
0 |
% |
Total Net Investment
Income |
$ |
23,564 |
|
|
$ |
21,799 |
|
|
|
8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
The Company’s annualized gross investment yield
on average fixed maturity, bank loan and equity securities for the
three months ended September 30, 2024 was 4.8% (versus 4.8% for the
three months ended September 30, 2023).
Net realized and unrealized gains on investments
of $4.2 million for the three months ended September 30, 2024
compared to net realized and unrealized gains on investments of
$0.7 million in the prior year quarter. The majority of the
realized and unrealized gains during the third quarter of 2024 were
related to changes in fair value of our common stock portfolio,
partially offset by realized losses on sales in our bank loan and
fixed income portfolios.
In connection with the closing of the E&S
ADC on July 2, the Company transferred approximately $310.0 million
in cash for the payment of the premium to counterparty, State
National Insurance Company, Inc.
Capital Management
The Company announced that its Board of Directors declared a
cash dividend of $0.01 per common share. This dividend is payable
on Tuesday, December 31, 2024 to all shareholders of record on
Monday, December 16, 2024.
Tangible Equity
Tangible equity5 of $491.9 million at
September 30, 2024 increased 1.4% compared to tangible equity
of $485.3 million at June 30, 2024, due to strong unrealized
investment gains in accumulated other comprehensive income ("AOCI")
as well as an increase in deferred reinsurance gain, partially
offset by a net loss from continuing and discontinued operations.
Other comprehensive income benefited by $31.1 million during the
third quarter of 2024, reducing AOCI to a loss of $42.8 million due
to an increase in the value of the Company's fixed maturity
securities caused by a decline in interest rates.
_______________5 Tangible equity and tangible
common equity excluding AOCI are non-GAAP financial measures. See
“Non-GAAP Financial Measures” and “Reconciliation of Non-GAAP
Financial Measures” at the end of this press release.
Conference Call
James River will hold a conference call to
discuss its third quarter results tomorrow, November 12, 2024 at
8:30 a.m. Eastern Time. Investors may access the conference call by
dialing (800) 715-9871, Conference ID 6261499, or via the internet
by visiting www.jrvrgroup.com and clicking on the “Investor
Relations” link. A webcast replay of the call will be available by
visiting the company website.
Forward-Looking Statements
This press release contains forward-looking
statements as that term is defined in the Private Securities
Litigation Reform Act of 1995. In some cases, such forward-looking
statements may be identified by terms such as believe, expect,
seek, may, will, should, intend, project, anticipate, plan,
estimate, guidance or similar words. Forward-looking statements
involve risks and uncertainties that could cause actual results to
differ materially from those in the forward-looking statements.
Although it is not possible to identify all of these risks and
uncertainties, they include, among others, the following: the
inherent uncertainty of estimating reserves and the possibility
that incurred losses may be greater than our loss and loss
adjustment expense reserves; inaccurate estimates and judgments in
our risk management may expose us to greater risks than intended;
downgrades in the financial strength rating or outlook of our
regulated insurance subsidiaries impacting our ability to attract
and retain insurance business that our subsidiaries write, our
competitive position, and our financial condition; the outcome of
our exploration of strategic alternatives, and market reaction
thereto; the failure to close the common equity and adverse
development cover reinsurance transactions with Enstar Group
Limited announced on November 11, 2024; the amount of the final
post-closing adjustment to the purchase price received in
connection with the sale of our casualty reinsurance business and
outcome of litigation relating to such transactions; the potential
loss of key members of our management team or key employees and our
ability to attract and retain personnel; adverse economic factors
resulting in the sale of fewer policies than expected or an
increase in the frequency or severity of claims, or both; the
impact of a higher than expected inflationary environment on our
reserves, the values of our investments and investment returns, and
our compensation expenses; exposure to credit risk, interest rate
risk and other market risk in our investment portfolio; reliance on
a select group of brokers and agents for a significant portion of
our business and the impact of our potential failure to maintain
such relationships; reliance on a select group of customers for a
significant portion of our business and the impact of our potential
failure to maintain, or decision to terminate, such relationships;
our ability to obtain insurance and reinsurance coverage at prices
and on terms that allow us to transfer risk, adequately protect our
company against financial loss and that supports our growth plans;
losses resulting from reinsurance counterparties failing to pay us
on reinsurance claims, insurance companies with whom we have a
fronting arrangement failing to pay us for claims, or a former
customer with whom we have an indemnification arrangement failing
to perform its reimbursement obligations, and our potential
inability to demand or maintain adequate collateral to mitigate
such risks; inadequacy of premiums we charge to compensate us for
our losses incurred; changes in laws or government regulation,
including tax or insurance law and regulations; changes in U.S. tax
laws and the interpretation of certain provisions of Public Law No.
115-97, informally titled the 2017 Tax Cuts and Jobs Act (including
associated regulations), which may be retroactive and could have a
significant effect on us including, among other things, by
potentially increasing our tax rate, as well as on our
shareholders; in the event we do not qualify for the insurance
company exception to the passive foreign investment company
(“PFIC”) rules and are therefore considered a PFIC, there could be
material adverse tax consequences to an investor that is subject to
U.S. federal income taxation; the Company or its foreign subsidiary
becoming subject to U.S. federal income taxation; a failure of any
of the loss limitations or exclusions we utilize to shield us from
unanticipated financial losses or legal exposures, or other
liabilities; losses from catastrophic events, such as natural
disasters and terrorist acts, which substantially exceed our
expectations and/or exceed the amount of reinsurance we have
purchased to protect us from such events; potential effects on our
business of emerging claim and coverage issues; the potential
impact of internal or external fraud, operational errors, systems
malfunctions or cyber security incidents; our ability to manage our
growth effectively; failure to maintain effective internal controls
in accordance with the Sarbanes-Oxley Act of 2002, as amended;
changes in our financial condition, regulations or other factors
that may restrict our subsidiaries’ ability to pay us dividends;
and an adverse result in any litigation or legal proceedings we are
or may become subject to. Additional information about these risks
and uncertainties, as well as others that may cause actual results
to differ materially from those in the forward-looking statements,
is contained in our filings with the U.S. Securities and Exchange
Commission ("SEC"), including our most recently filed Annual Report
on Form 10-K and Quarterly Report on Form 10-Q. These
forward-looking statements speak only as of the date of this
release and the Company does not undertake any obligation to update
or revise any forward-looking information to reflect changes in
assumptions, the occurrence of unanticipated events, or
otherwise.
Non-GAAP Financial Measures
In presenting James River Group Holdings, Ltd.’s
results, management has included financial measures that are not
calculated under standards or rules that comprise accounting
principles generally accepted in the United States (“GAAP”). Such
measures, including underwriting (loss) profit, adjusted net
operating (loss) income, tangible equity, tangible common equity,
adjusted net operating return on tangible equity (which is
calculated as annualized adjusted net operating income divided by
the average quarterly tangible equity balances in the respective
period), and adjusted net operating return on tangible common
equity excluding AOCI (which is calculated as annualized adjusted
net operating income divided by the average quarterly tangible
common equity balances in the respective period, excluding AOCI),
are referred to as non-GAAP measures. These non-GAAP measures may
be defined or calculated differently by other companies. These
measures should not be viewed as a substitute for those measures
determined in accordance with GAAP. Reconciliations of such
measures to the most comparable GAAP figures are included at the
end of this press release.
About James River Group Holdings,
Ltd.
James River Group Holdings, Ltd. is a
Bermuda-based insurance holding company that owns and operates a
group of specialty insurance companies. The Company operates in two
specialty property-casualty insurance segments: Excess and Surplus
Lines and Specialty Admitted Insurance. Each of the Company’s
regulated insurance subsidiaries are rated “A-” (Excellent) by A.M.
Best Company.
Visit James River Group Holdings, Ltd. on the
web at www.jrvrgroup.com
James River Group Holdings, Ltd. and
SubsidiariesCondensed Consolidated Balance Sheet
Data (Unaudited) |
|
($ in thousands,
except for share data) |
September 30, 2024 |
|
December 31, 2023 |
ASSETS |
|
|
|
Invested assets: |
|
|
|
Fixed maturity securities, available-for-sale, at fair value |
$ |
1,215,244 |
|
|
$ |
1,324,476 |
|
Equity securities, at fair
value |
|
131,187 |
|
|
|
119,945 |
|
Bank loan participations, at
fair value |
|
149,113 |
|
|
|
156,169 |
|
Short-term investments |
|
43,588 |
|
|
|
72,137 |
|
Other invested assets |
|
35,932 |
|
|
|
33,134 |
|
Total invested assets |
|
1,575,064 |
|
|
|
1,705,861 |
|
|
|
|
|
Cash and cash equivalents |
|
359,773 |
|
|
|
274,298 |
|
Restricted cash equivalents
(a) |
|
28,364 |
|
|
|
72,449 |
|
Accrued investment income |
|
10,248 |
|
|
|
12,106 |
|
Premiums receivable and
agents’ balances, net |
|
202,575 |
|
|
|
249,490 |
|
Reinsurance recoverable on
unpaid losses, net |
|
1,939,388 |
|
|
|
1,358,474 |
|
Reinsurance recoverable on
paid losses |
|
133,257 |
|
|
|
157,991 |
|
Deferred policy acquisition
costs |
|
27,279 |
|
|
|
31,497 |
|
Goodwill and intangible
assets |
|
214,372 |
|
|
|
214,644 |
|
Other assets |
|
468,411 |
|
|
|
457,047 |
|
Assets of discontinued
operations held-for-sale |
|
0 |
|
|
|
783,393 |
|
Total assets |
$ |
4,958,731 |
|
|
$ |
5,317,250 |
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS’ EQUITY |
|
|
|
Reserve for losses and loss
adjustment expenses |
$ |
3,001,913 |
|
|
$ |
2,606,107 |
|
Unearned premiums |
|
577,074 |
|
|
|
587,899 |
|
Funds held (a) |
|
25,157 |
|
|
|
65,235 |
|
Deferred reinsurance gain |
|
31,001 |
|
|
|
20,733 |
|
Senior debt |
|
200,800 |
|
|
|
222,300 |
|
Junior subordinated debt |
|
104,055 |
|
|
|
104,055 |
|
Accrued expenses |
|
51,991 |
|
|
|
56,722 |
|
Other liabilities |
|
291,495 |
|
|
|
333,183 |
|
Liabilities of discontinued
operations held-for-sale |
|
0 |
|
|
|
641,497 |
|
Total liabilities |
|
4,283,486 |
|
|
|
4,637,731 |
|
|
|
|
|
Series A redeemable preferred
shares |
|
144,898 |
|
|
|
144,898 |
|
Total shareholders’
equity |
|
530,347 |
|
|
|
534,621 |
|
Total liabilities, Series A
redeemable preferred shares, and shareholders’ equity |
$ |
4,958,731 |
|
|
$ |
5,317,250 |
|
|
|
|
|
Tangible equity (b) |
$ |
491,874 |
|
|
$ |
485,608 |
|
Tangible equity per share
(b) |
$ |
11.01 |
|
|
$ |
11.13 |
|
Tangible common equity per
share (b) |
$ |
9.17 |
|
|
$ |
9.05 |
|
Shareholders' equity per
share |
$ |
14.02 |
|
|
$ |
14.20 |
|
Common shares outstanding |
|
37,829,475 |
|
|
|
37,641,563 |
|
|
|
|
|
(a) Restricted cash equivalents and the funds held liability
includes funds posted by the Company to a trust account for the
benefit of a third party administrator handling the claims on the
Rasier commercial auto policies in run-off. Such funds held in
trust secure the Company's obligations to reimburse the
administrator for claims payments, and are primarily sourced from
the collateral posted to the Company by Rasier and its affiliates
to support their obligations under the indemnity agreements and the
loss portfolio transfer reinsurance agreement with the
Company. |
(b) See “Reconciliation of
Non-GAAP Measures” |
|
|
|
|
|
|
|
James River Group Holdings, Ltd. and
SubsidiariesCondensed Consolidated Income
Statement Data (Unaudited) |
|
|
Three Months EndedSeptember
30, |
|
Nine Months EndedSeptember
30, |
($ in thousands, except for share data) |
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
REVENUES |
|
|
|
|
|
|
|
Gross written premiums |
$ |
330,423 |
|
|
$ |
342,851 |
|
|
$ |
1,073,480 |
|
|
$ |
1,119,355 |
|
Net written premiums |
|
147,338 |
|
|
|
145,982 |
|
|
|
466,863 |
|
|
|
521,700 |
|
|
|
|
|
|
|
|
|
Net earned premiums |
|
159,726 |
|
|
|
183,673 |
|
|
|
494,610 |
|
|
|
526,052 |
|
Net investment income |
|
23,564 |
|
|
|
21,799 |
|
|
|
71,127 |
|
|
|
58,458 |
|
Net realized and unrealized
gains on investments |
|
4,150 |
|
|
|
712 |
|
|
|
6,428 |
|
|
|
2,487 |
|
Other income |
|
4,057 |
|
|
|
4,135 |
|
|
|
8,748 |
|
|
|
6,908 |
|
Total revenues |
|
191,497 |
|
|
|
210,319 |
|
|
|
580,913 |
|
|
|
593,905 |
|
|
|
|
|
|
|
|
|
EXPENSES |
|
|
|
|
|
|
|
Losses and loss adjustment
expenses (a) |
|
184,294 |
|
|
|
120,174 |
|
|
|
409,814 |
|
|
|
366,995 |
|
Other operating expenses |
|
51,224 |
|
|
|
49,693 |
|
|
|
146,130 |
|
|
|
147,922 |
|
Other expenses |
|
1,752 |
|
|
|
641 |
|
|
|
4,582 |
|
|
|
1,467 |
|
Interest expense |
|
6,128 |
|
|
|
6,486 |
|
|
|
18,957 |
|
|
|
18,066 |
|
Intangible asset amortization
and impairment |
|
90 |
|
|
|
2,590 |
|
|
|
272 |
|
|
|
2,772 |
|
Total expenses |
|
243,488 |
|
|
|
179,584 |
|
|
|
579,755 |
|
|
|
537,222 |
|
(Loss) income from continuing
operations before income taxes |
|
(51,991 |
) |
|
|
30,735 |
|
|
|
1,158 |
|
|
|
56,683 |
|
Income tax (benefit) expense
on continuing operations |
|
(13,914 |
) |
|
|
7,013 |
|
|
|
1,249 |
|
|
|
15,530 |
|
Net (loss) income from
continuing operations |
$ |
(38,077 |
) |
|
$ |
23,722 |
|
|
|
(91 |
) |
|
|
41,153 |
|
Net (loss) income from
discontinued operations |
|
(1,304 |
) |
|
|
(4,171 |
) |
|
|
(16,262 |
) |
|
|
1,318 |
|
NET (LOSS)
INCOME |
|
(39,381 |
) |
|
|
19,551 |
|
|
|
(16,353 |
) |
|
|
42,471 |
|
Dividends on Series A
preferred shares |
|
(2,625 |
) |
|
|
(2,625 |
) |
|
|
(7,875 |
) |
|
|
(7,875 |
) |
NET (LOSS) INCOME
AVAILABLE TO COMMON SHAREHOLDERS |
$ |
(42,006 |
) |
|
$ |
16,926 |
|
|
$ |
(24,228 |
) |
|
$ |
34,596 |
|
ADJUSTED NET OPERATING
(LOSS) INCOME (b) |
$ |
(28,196 |
) |
|
$ |
18,859 |
|
|
$ |
(700 |
) |
|
$ |
37,875 |
|
|
|
|
|
|
|
|
|
INCOME (LOSS) PER
COMMON SHARE |
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
|
|
Continuing operations |
$ |
(1.07 |
) |
|
$ |
0.56 |
|
|
$ |
(0.21 |
) |
|
$ |
0.88 |
|
Discontinued operations |
$ |
(0.03 |
) |
|
$ |
(0.11 |
) |
|
$ |
(0.43 |
) |
|
$ |
0.04 |
|
|
$ |
(1.10 |
) |
|
$ |
0.45 |
|
|
$ |
(0.64 |
) |
|
$ |
0.92 |
|
Diluted |
|
|
|
|
|
|
|
Continuing operations |
$ |
(1.07 |
) |
|
$ |
0.55 |
|
|
$ |
(0.21 |
) |
|
$ |
0.88 |
|
Discontinued operations |
$ |
(0.03 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.43 |
) |
|
$ |
0.03 |
|
|
$ |
(1.10 |
) |
|
$ |
0.45 |
|
|
$ |
(0.64 |
) |
|
$ |
0.91 |
|
|
|
|
|
|
|
|
|
ADJUSTED
NET OPERATING (LOSS) INCOME PER COMMON SHARE |
|
|
|
|
Basic |
$ |
(0.74 |
) |
|
$ |
0.50 |
|
|
$ |
(0.02 |
) |
|
$ |
1.01 |
|
Diluted (c) |
$ |
(0.74 |
) |
|
$ |
0.49 |
|
|
$ |
(0.02 |
) |
|
$ |
1.00 |
|
|
|
|
|
|
|
|
|
Weighted-average common shares
outstanding: |
|
|
|
|
|
|
|
Basic |
|
37,880,297 |
|
|
|
37,642,632 |
|
|
|
37,827,968 |
|
|
|
37,605,986 |
|
Diluted |
|
37,880,297 |
|
|
|
43,463,064 |
|
|
|
37,827,968 |
|
|
|
37,822,774 |
|
Cash dividends declared per
common share |
$ |
0.05 |
|
|
$ |
0.05 |
|
|
$ |
0.15 |
|
|
$ |
0.15 |
|
|
|
|
|
|
|
|
|
Ratios: |
|
|
|
|
|
|
|
Loss ratio |
|
104.1 |
% |
|
|
67.2 |
% |
|
|
80.8 |
% |
|
|
68.6 |
% |
Expense ratio (d) |
|
31.4 |
% |
|
|
26.4 |
% |
|
|
28.8 |
% |
|
|
27.4 |
% |
Combined ratio |
|
135.5 |
% |
|
|
93.6 |
% |
|
|
109.6 |
% |
|
|
96.0 |
% |
Accident year loss ratio
(e) |
|
66.4 |
% |
|
|
62.9 |
% |
|
|
66.3 |
% |
|
|
65.8 |
% |
|
|
|
|
|
|
|
|
(a) Losses and loss adjustment expenses include expenses of $18.0
million and $10.3 million for deferred retroactive reinsurance
gains for the three and nine months ended September 30, 2024,
respectively ($3.2 million of benefit and $6.3 million of expense
in the respective prior year periods). |
(b) See "Reconciliation of Non-GAAP Measures". |
(c) For the three months ended September 30, 2023, the outstanding
Series A preferred shares were dilutive. Dividends on the Series A
preferred shares were added back to the numerator of the
calculation and 5,640,158 common shares from an assumed conversion
of the Series A preferred shares were included in the
denominator. |
(d) Calculated with a numerator comprising other operating expenses
less gross fee income (in specific instances when the Company is
not retaining insurance risk) included in “Other income” in our
Condensed Consolidated Income Statements of $1.1 million and $3.7
million for the three and nine months ended September 30,
2024, respectively ($1.2 million and $3.6 million in the respective
prior year periods). |
(e) Ratio of losses and loss adjustment expenses for the current
accident year, excluding development on prior accident year
reserves, to net earned premiums for the current year (excluding
net earned premium adjustments on certain reinsurance treaties with
reinstatement premiums associated with prior years). |
|
James River Group Holdings, Ltd. and
SubsidiariesSegment Results |
|
EXCESS AND SURPLUS LINES
|
Three Months EndedSeptember
30, |
|
|
|
Nine Months EndedSeptember
30, |
|
|
($ in
thousands) |
|
2024 |
|
|
|
2023 |
|
|
% Change |
|
|
2024 |
|
|
|
2023 |
|
|
% Change |
Gross written premiums |
$ |
230,215 |
|
|
$ |
217,151 |
|
|
|
6.0 |
% |
|
$ |
736,742 |
|
|
$ |
732,180 |
|
|
|
0.6 |
% |
Net written premiums |
$ |
129,735 |
|
|
$ |
123,046 |
|
|
|
5.4 |
% |
|
$ |
408,761 |
|
|
$ |
442,923 |
|
|
|
(7.7 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earned premiums |
$ |
138,892 |
|
|
$ |
157,600 |
|
|
|
(11.9 |
)% |
|
$ |
424,962 |
|
|
$ |
455,640 |
|
|
|
(6.7 |
)% |
Losses and loss adjustment
expenses excluding retroactive reinsurance |
|
(150,249 |
) |
|
|
(103,077 |
) |
|
|
45.8 |
% |
|
|
(345,387 |
) |
|
|
(307,364 |
) |
|
|
12.4 |
% |
Underwriting expenses |
|
(38,798 |
) |
|
|
(36,181 |
) |
|
|
7.2 |
% |
|
|
(104,812 |
) |
|
|
(102,827 |
) |
|
|
1.9 |
% |
Underwriting (loss) profit
(a) |
$ |
(50,155 |
) |
|
$ |
18,342 |
|
|
|
— |
|
|
$ |
(25,237 |
) |
|
$ |
45,449 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratios: |
|
|
|
|
|
|
|
|
|
|
|
Loss ratio |
|
108.2 |
% |
|
|
65.4 |
% |
|
|
|
|
81.3 |
% |
|
|
67.5 |
% |
|
|
Expense ratio |
|
27.9 |
% |
|
|
23.0 |
% |
|
|
|
|
24.6 |
% |
|
|
22.5 |
% |
|
|
Combined ratio |
|
136.1 |
% |
|
|
88.4 |
% |
|
|
|
|
105.9 |
% |
|
|
90.0 |
% |
|
|
Accident year loss ratio
(b) |
|
64.7 |
% |
|
|
60.4 |
% |
|
|
|
|
64.4 |
% |
|
|
64.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) See
"Reconciliation of Non-GAAP Measures". |
(b) Ratio of
losses and loss adjustment expenses for the current accident year,
excluding development on prior accident year reserves, to net
earned premiums for the current year (excluding net earned premium
adjustments on certain reinsurance treaties with reinstatement
premiums associated with prior years). |
|
SPECIALTY ADMITTED INSURANCE
|
Three Months EndedSeptember
30, |
|
|
|
|
|
Nine Months EndedSeptember
30, |
|
|
($ in
thousands) |
|
2024 |
|
|
|
2023 |
|
|
|
% Change |
|
|
|
2024 |
|
|
|
2023 |
|
|
% Change |
Gross written premiums |
$ |
100,208 |
|
|
$ |
125,700 |
|
|
|
(20.3 |
)% |
|
$ |
336,738 |
|
|
$ |
387,175 |
|
|
|
(13.0 |
)% |
Net written premiums |
$ |
17,603 |
|
|
$ |
22,936 |
|
|
|
(23.3 |
)% |
|
$ |
58,102 |
|
|
$ |
78,777 |
|
|
|
(26.2 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earned premiums |
$ |
20,834 |
|
|
$ |
26,073 |
|
|
|
(20.1 |
)% |
|
$ |
69,648 |
|
|
$ |
70,412 |
|
|
|
(1.1 |
)% |
Losses and loss adjustment
expenses |
|
(16,091 |
) |
|
|
(20,284 |
) |
|
|
(20.7 |
)% |
|
|
(54,159 |
) |
|
|
(53,370 |
) |
|
|
1.5 |
% |
Underwriting expenses |
|
(2,933 |
) |
|
|
(3,822 |
) |
|
|
(23.3 |
)% |
|
|
(9,477 |
) |
|
|
(15,160 |
) |
|
|
(37.5 |
)% |
Underwriting profit (a),
(b) |
$ |
1,810 |
|
|
$ |
1,967 |
|
|
|
(8.0 |
)% |
|
$ |
6,012 |
|
|
$ |
1,882 |
|
|
|
219.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ratios: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio |
|
77.2 |
% |
|
|
77.8 |
% |
|
|
|
|
|
|
77.8 |
% |
|
|
75.8 |
% |
|
|
Expense ratio |
|
14.1 |
% |
|
|
14.7 |
% |
|
|
|
|
|
|
13.6 |
% |
|
|
21.5 |
% |
|
|
Combined ratio |
|
91.3 |
% |
|
|
92.5 |
% |
|
|
|
|
|
|
91.4 |
% |
|
|
97.3 |
% |
|
|
Accident year loss ratio |
|
78.0 |
% |
|
|
77.8 |
% |
|
|
|
|
|
|
78.6 |
% |
|
|
77.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) See
"Reconciliation of Non-GAAP Measures". |
|
|
|
|
|
|
|
|
|
|
|
|
(b) Underwriting results for the three and nine months ended
September 30, 2024 include gross fee income of $5.2 million
and $16.1 million, respectively ($6.8 million and $18.3 million in
the respective prior year periods). |
|
Underwriting Performance Ratios
The following table provides the underwriting
performance ratios of the Company's continuing operations inclusive
of the business subject to retroactive reinsurance accounting for
loss portfolio transfers. There is no economic impact to the
Company over the life of a loss portfolio transfer contract so long
as any additional losses subject to the contract are within the
limit of the loss portfolio transfer and the counterparty performs
under the contract. Retroactive reinsurance accounting is not
indicative of our current and ongoing operations. Management
believes that providing loss ratios and combined ratios on business
not subject to retroactive reinsurance accounting for loss
portfolio transfers gives the users of our financial statements
useful information in evaluating our current and ongoing
operations.
|
Three Months EndedSeptember
30, |
|
Nine Months EndedSeptember
30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Excess and Surplus
Lines: |
|
|
|
|
|
|
|
Loss Ratio |
|
108.2 |
% |
|
|
65.4 |
% |
|
|
81.3 |
% |
|
|
67.5 |
% |
Impact of retroactive
reinsurance |
|
12.9 |
% |
|
|
(2.0 |
)% |
|
|
2.4 |
% |
|
|
1.4 |
% |
Loss Ratio including impact of
retroactive reinsurance |
|
121.1 |
% |
|
|
63.4 |
% |
|
|
83.7 |
% |
|
|
68.9 |
% |
|
|
|
|
|
|
|
|
|
|
Combined Ratio |
|
136.1 |
% |
|
|
88.4 |
% |
|
|
105.9 |
% |
|
|
90.0 |
% |
Impact of retroactive
reinsurance |
|
12.9 |
% |
|
|
(2.0 |
)% |
|
|
2.4 |
% |
|
|
1.4 |
% |
Combined Ratio including
impact of retroactive reinsurance |
|
149.0 |
% |
|
|
86.4 |
% |
|
|
108.3 |
% |
|
|
91.4 |
% |
|
|
|
|
|
|
|
|
|
|
Consolidated: |
|
|
|
|
|
|
|
|
|
Loss Ratio |
|
104.1 |
% |
|
|
67.2 |
% |
|
|
80.8 |
% |
|
|
68.6 |
% |
Impact of retroactive
reinsurance |
|
11.2 |
% |
|
|
(1.7 |
)% |
|
|
2.1 |
% |
|
|
1.2 |
% |
Loss Ratio including impact of
retroactive reinsurance |
|
115.3 |
% |
|
|
65.5 |
% |
|
|
82.9 |
% |
|
|
69.8 |
% |
|
|
|
|
|
|
|
|
|
|
Combined Ratio |
|
135.5 |
% |
|
|
93.6 |
% |
|
|
109.6 |
% |
|
|
96.0 |
% |
Impact of retroactive
reinsurance |
|
11.2 |
% |
|
|
(1.7 |
)% |
|
|
2.1 |
% |
|
|
1.2 |
% |
Combined Ratio including
impact of retroactive reinsurance |
|
146.7 |
% |
|
|
91.9 |
% |
|
|
111.7 |
% |
|
|
97.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RECONCILIATION OF NON-GAAP MEASURES
Underwriting Profit
The following table reconciles the underwriting
profit by individual operating segment and for the entire Company
to consolidated income from continuing operations before taxes. We
believe that the disclosure of underwriting profit by individual
segment and of the Company as a whole is useful to investors,
analysts, rating agencies and other users of our financial
information in evaluating our performance because our objective is
to consistently earn underwriting profits. We evaluate the
performance of our segments and allocate resources based primarily
on underwriting profit. We define underwriting profit as net earned
premiums and gross fee income (in specific instances when the
Company is not retaining insurance risk) less losses and loss
adjustment expenses on business from continuing operations not
subject to retroactive reinsurance accounting for loss portfolio
transfers and other operating expenses. Other operating expenses
include the underwriting, acquisition, and insurance expenses of
the operating segments and, for consolidated underwriting profit,
the expenses of the Corporate and Other segment. Our definition of
underwriting profit may not be comparable to that of other
companies.
|
Three Months EndedSeptember
30, |
|
Nine Months EndedSeptember
30, |
($ in thousands) |
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Underwriting (loss) profit of
the operating segments: |
|
|
|
|
|
|
|
Excess and Surplus Lines |
$ |
(50,155 |
) |
|
$ |
18,342 |
|
|
$ |
(25,237 |
) |
|
$ |
45,449 |
|
Specialty Admitted Insurance |
|
1,810 |
|
|
|
1,967 |
|
|
|
6,012 |
|
|
|
1,882 |
|
Total underwriting profit of
operating segments |
|
(48,345 |
) |
|
|
20,309 |
|
|
|
(19,225 |
) |
|
|
47,331 |
|
Other operating expenses of
the Corporate and Other segment |
|
(8,421 |
) |
|
|
(8,482 |
) |
|
|
(28,182 |
) |
|
|
(26,312 |
) |
Underwriting (loss) profit
(a) |
|
(56,766 |
) |
|
|
11,827 |
|
|
|
(47,407 |
) |
|
|
21,019 |
|
Losses and loss adjustment
expenses - retroactive reinsurance |
|
(17,954 |
) |
|
|
3,187 |
|
|
|
(10,268 |
) |
|
|
(6,261 |
) |
Net investment income |
|
23,564 |
|
|
|
21,799 |
|
|
|
71,127 |
|
|
|
58,458 |
|
Net realized and unrealized
gains on investments |
|
4,150 |
|
|
|
712 |
|
|
|
6,428 |
|
|
|
2,487 |
|
Other income (expense) |
|
1,233 |
|
|
|
2,286 |
|
|
|
507 |
|
|
|
1,818 |
|
Interest expense |
|
(6,128 |
) |
|
|
(6,486 |
) |
|
|
(18,957 |
) |
|
|
(18,066 |
) |
Amortization of intangible
assets |
|
(90 |
) |
|
|
(90 |
) |
|
|
(272 |
) |
|
|
(272 |
) |
Impairment of IRWC trademark
intangible asset |
|
— |
|
|
|
(2,500 |
) |
|
|
— |
|
|
|
(2,500 |
) |
(Loss) income from continuing
operations before taxes |
$ |
(51,991 |
) |
|
$ |
30,735 |
|
|
$ |
1,158 |
|
|
$ |
56,683 |
|
|
|
|
|
|
|
|
|
(a) Included in underwriting results for the three and nine months
ended September 30, 2024 is gross fee income of $5.2 million
and $16.1 million, respectively ($6.8 million and $18.3 million in
the respective prior year periods). |
|
Adjusted Net Operating
Income
We define adjusted net operating income as
income available to common shareholders excluding a) income (loss)
from discontinued operations b) the impact of retroactive
reinsurance accounting for loss portfolio transfers, c) net
realized and unrealized gains (losses) on investments, d) certain
non-operating expenses such as professional service fees related to
various strategic initiatives, and the filing of registration
statements for the offering of securities, and e) severance costs
associated with terminated employees. We use adjusted net operating
income as an internal performance measure in the management of our
operations because we believe it gives our management and other
users of our financial information useful insight into our results
of operations and our underlying business performance. Adjusted net
operating income should not be viewed as a substitute for net
income calculated in accordance with GAAP, and our definition of
adjusted net operating income may not be comparable to that of
other companies.
Our (loss) income available to common
shareholders reconciles to our adjusted net operating (loss) income
as follows:
|
Three Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
($ in
thousands) |
LossBeforeTaxes |
|
NetLoss |
|
IncomeBeforeTaxes |
|
NetIncome |
(Loss) income available to common shareholders |
$ |
(55,920 |
) |
|
$ |
(42,006 |
) |
|
$ |
23,939 |
|
|
$ |
16,926 |
|
Loss from discontinued
operations |
|
1,304 |
|
|
|
1,304 |
|
|
|
4,171 |
|
|
|
4,171 |
|
Losses and loss adjustment
expenses - retroactive reinsurance |
|
17,954 |
|
|
|
14,184 |
|
|
|
(3,187 |
) |
|
|
(2,518 |
) |
Net realized and unrealized
investment gains |
|
(4,150 |
) |
|
|
(3,279 |
) |
|
|
(712 |
) |
|
|
(562 |
) |
Other expenses |
|
1,752 |
|
|
|
1,601 |
|
|
|
(1,531 |
) |
|
|
(1,133 |
) |
Impairment of IRWC trademark
intangible asset |
|
— |
|
|
|
— |
|
|
|
2,500 |
|
|
|
1,975 |
|
Adjusted net operating (loss)
income |
$ |
(39,060 |
) |
|
$ |
(28,196 |
) |
|
$ |
25,180 |
|
|
$ |
18,859 |
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
|
2024 |
|
|
|
2023 |
|
($ in
thousands) |
(Loss)
IncomeBeforeTaxes |
|
NetLoss |
|
IncomeBeforeTaxes |
|
NetIncome |
(Loss) income available to
common shareholders |
$ |
(22,979 |
) |
|
$ |
(24,228 |
) |
|
$ |
50,126 |
|
|
$ |
34,596 |
|
Loss (income) from
discontinued operations |
|
16,262 |
|
|
|
16,262 |
|
|
|
(1,318 |
) |
|
|
(1,318 |
) |
Losses and loss adjustment
expenses - retroactive reinsurance |
|
10,268 |
|
|
|
8,112 |
|
|
|
6,261 |
|
|
|
4,946 |
|
Net realized and unrealized
investment gains |
|
(6,428 |
) |
|
|
(5,079 |
) |
|
|
(2,487 |
) |
|
|
(1,964 |
) |
Other expenses |
|
4,582 |
|
|
|
4,233 |
|
|
|
(733 |
) |
|
|
(360 |
) |
Impairment of IRWC trademark
intangible asset |
|
— |
|
|
|
— |
|
|
|
2,500 |
|
|
|
1,975 |
|
Adjusted net operating income
(loss) |
$ |
1,705 |
|
|
$ |
(700 |
) |
|
$ |
54,349 |
|
|
$ |
37,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tangible Equity (per Share) and Tangible
Common Equity (per Share)
We define tangible equity as shareholders'
equity plus mezzanine Series A preferred shares and the
unrecognized deferred retroactive reinsurance gain on loss
portfolio transfers less goodwill and intangible assets (net of
amortization). We define tangible common equity as tangible equity
less mezzanine Series A preferred shares. Our definition of
tangible equity and tangible common equity may not be comparable to
that of other companies, and it should not be viewed as a
substitute for shareholders’ equity calculated in accordance with
GAAP. We use tangible equity and tangible common equity internally
to evaluate the strength of our balance sheet and to compare
returns relative to this measure. The following table reconciles
shareholders’ equity to tangible equity and tangible common equity
for September 30, 2024, June 30, 2024, December 31, 2023,
and September 30, 2023.
|
September 30, 2024 |
|
June 30, 2024 |
|
December 31, 2023 |
|
September 30, 2023 |
($ in thousands,
except for share data) |
|
|
|
|
|
|
|
Shareholders' equity |
$ |
530,347 |
|
|
$ |
541,791 |
|
|
$ |
534,621 |
|
|
$ |
562,544 |
|
Plus: Series A redeemable
preferred shares |
|
144,898 |
|
|
|
144,898 |
|
|
|
144,898 |
|
|
|
144,898 |
|
Plus: Deferred reinsurance
gain (a) |
|
31,001 |
|
|
|
13,047 |
|
|
|
20,733 |
|
|
|
37,653 |
|
Less: Goodwill and intangible
assets |
|
214,372 |
|
|
|
214,462 |
|
|
|
214,644 |
|
|
|
214,735 |
|
Tangible equity |
$ |
491,874 |
|
|
$ |
485,274 |
|
|
$ |
485,608 |
|
|
$ |
530,360 |
|
Less: Series A redeemable
preferred shares |
|
144,898 |
|
|
|
144,898 |
|
|
|
144,898 |
|
|
|
144,898 |
|
Tangible common equity |
$ |
346,976 |
|
|
$ |
340,376 |
|
|
$ |
340,710 |
|
|
$ |
385,462 |
|
|
|
|
|
|
|
|
|
Common shares outstanding |
|
37,829,475 |
|
|
|
37,825,767 |
|
|
|
37,641,563 |
|
|
|
37,619,749 |
|
Common shares from assumed
conversion of Series A preferred shares |
|
6,848,763 |
|
|
|
6,848,763 |
|
|
|
5,971,184 |
|
|
|
5,640,158 |
|
Common shares outstanding
after assumed conversion of Series A preferred shares |
|
44,678,238 |
|
|
|
44,674,530 |
|
|
|
43,612,747 |
|
|
|
43,259,907 |
|
|
|
|
|
|
|
|
|
Equity per share: |
|
|
|
|
|
|
|
Shareholders' equity |
$ |
14.02 |
|
|
$ |
14.32 |
|
|
$ |
14.20 |
|
|
$ |
14.95 |
|
Tangible equity |
$ |
11.01 |
|
|
$ |
10.86 |
|
|
$ |
11.13 |
|
|
$ |
12.26 |
|
Tangible common equity |
$ |
9.17 |
|
|
$ |
9.00 |
|
|
$ |
9.05 |
|
|
$ |
10.25 |
|
|
|
|
|
|
|
|
|
(a) Deferred reinsurance gain for the period ending September 30,
2023 includes the deferred retroactive reinsurance gain of $15.7
million related to the former Casualty Reinsurance LPT. |
|
For more information contact:
Zachary Shytle
Senior Analyst, Investments and Investor Relations
980-249-6848
InvestorRelations@james-river-group.com
James River (NASDAQ:JRVR)
過去 株価チャート
から 10 2024 まで 11 2024
James River (NASDAQ:JRVR)
過去 株価チャート
から 11 2023 まで 11 2024